Cargando…
SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1
BACKGROUND: Endothelial–mesenchymal transition (EndMT) plays a crucial role in promoting myocardial fibrosis and exacerbating cardiac dysfunction. Dapagliflozin (DAPA) is a sodium–glucose-linked transporter 2 (SGLT-2) inhibitor that has been shown to improve cardiac function in non-diabetic patients...
Autores principales: | Wang, Weijie, Li, Yilan, Zhang, Yanxiu, Ye, Tao, Wang, Kui, Li, Shuijie, Zhang, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685714/ https://www.ncbi.nlm.nih.gov/pubmed/38017499 http://dx.doi.org/10.1186/s12933-023-02040-x |
Ejemplares similares
-
Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes
por: Yasuzawa, Toshinori, et al.
Publicado: (2021) -
To be EndMT or not to be, that is the question in pulmonary hypertension
por: Xiong, Jianhua
Publicado: (2015) -
PTH‐induced EndMT via miR‐29a‐5p/GSAP/Notch1 pathway contributed to valvular calcification in rats with CKD
por: Wang, Liting, et al.
Publicado: (2021) -
Single cell meta-analysis of EndMT and EMT state in COVID-19
por: Zhang, Lanlan, et al.
Publicado: (2022) -
Cytoskeleton Reorganization in EndMT—The Role in Cancer and Fibrotic Diseases
por: Ciszewski, Wojciech Michał, et al.
Publicado: (2021)